Related Experiment Video
Updated: Mar 2, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis
Serena Camassa1, Ivana Palucci1, Raffaella Iantomasi2
1Institute of Microbiology, Università Cattolica del Sacro Cuore - Fondazione Policlinico Universitario GemelliRome, Italy.
Abstract:
PE_PGRS33 is a surface-exposed protein of Mycobacterium tuberculosis (Mtb) which exerts its role in macrophages entry and immunomodulation. In this study, we aimed to investigate the polymorphisms in the pe_pgrs33 gene of Mtb clinical isolates and evaluate their impact on protein functions. We sequenced pe_pgrs33 in a collection of 135 clinical strains, genotyped by 15-loci MIRU-VNTR and spoligotyping and belonging to the Mtb complex (MTBC). Overall, an association between pe_pgrs33 alleles and MTBC genotypes was observed and a dN/dS ratio of 0.64 was obtained, suggesting that a purifying selective pressure is acting on pe_pgrs33 against deleterious SNPs. Among a total of 19 pe_pgrs33 alleles identified in this study, 5 were cloned and used to complement the pe_pgrs33 knock-out mutant strain of Mtb H37Rv (MtbΔ33) to assess the functional impact of the respective polymorphisms in in vitro infections of primary macrophages. In human monocyte-derived macrophages (MDMs) infection, large in-frame and frameshift mutations were unable to restore the phenotype of Mtb H37Rv, impairing the cell entry capacity of Mtb, but neither its intracellular replication rate nor its immunomodulatory properties. In vivo studies performed in the murine model of tuberculosis (TB) demonstrated that the MtbΔ33 mutant strain was not impaired in the ability to infect and replicate in the lung tissue compared to the parental strain. Interestingly, MtbΔ33 showed an enhanced virulence during the chronic steps of infection compared to Mtb H37Rv. Similarly, the complementation of MtbΔ33 with a frameshift allele also resulted in a Mtb strain capable of causing a surprisingly enhanced tissue damage in murine lungs, during the chronic steps of infection. Together, these results further support the role of PE_PGRS33 in the pathogenesis and virulence of Mtb.
Insights
Polymorphisms in the PE_PGRS33 gene of Mycobacterium tuberculosis (Mtb) impact its function in macrophages and virulence. Mutations impair Mtb entry but enhance tissue damage, suggesting PE_PGRS33
Area of Science:
- Microbiology
- Genetics
- Immunology
Background:
- PE_PGRS33 is a surface protein of Mycobacterium tuberculosis (Mtb) involved in macrophage entry and immunomodulation.
- Understanding genetic variations in PE_PGRS33 is crucial for elucidating Mtb pathogenesis.
Purpose of the Study:
- To investigate polymorphisms in the pe_pgrs33 gene of Mtb clinical isolates.
- To evaluate the functional impact of these polymorphisms on Mtb virulence and host-pathogen interactions.
Main Methods:
- Sequencing of the pe_pgrs33 gene in 135 Mtb clinical strains.
- Genotyping using 15-loci MIRU-VNTR and spoligotyping.
- Functional analysis of complemented Mtb knockout mutants in vitro (macrophage infection) and in vivo (murine TB model).
Main Results:
- An association was observed between pe_pgrs33 alleles and Mtb complex (MTBC) genotypes, with evidence of purifying selection on the gene.
- Large mutations in pe_pgrs33 impaired Mtb entry into macrophages but not intracellular replication or immunomodulation.
- Mtb lacking PE_PGRS33 (MtbΔ33) showed enhanced virulence and caused greater lung tissue damage during chronic infection in mice.
Conclusions:
- PE_PGRS33 plays a significant role in Mtb pathogenesis and virulence.
- Specific polymorphisms in pe_pgrs33 can modulate Mtb's interaction with the host, leading to increased tissue damage.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pharmacogenomics: Identification of New Drug Targets

